Regulation
E2 wins FDA clearances for integrated Hēlo thrombectomy platform
E2 received FDA clearances for its integrated Hēlo thrombectomy platform, which includes the Hēlo Return system that aspirates blood during thrombectomy procedures and returns it to patients. The clearances enable broader clinical deployment of the VTE treatment workflow.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network